(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|
Turnover | -40.64%965.28M | -49.58%2.57B | --1.63B | 10.82%5.1B | 24.87%4.6B | 30.12%3.68B | 42.04%2.83B | --1.99B |
Operating income | -40.64%965.28M | -49.58%2.57B | 1.63B | 10.82%5.1B | 24.87%4.6B | 30.12%3.68B | 42.04%2.83B | 1.99B |
Cost of sales | 38.14%-725.35M | 49.14%-1.93B | ---1.17B | -12.51%-3.8B | -26.38%-3.38B | -25.73%-2.67B | -25.67%-2.13B | ---1.69B |
Operating expenses | 38.14%-725.35M | 49.14%-1.93B | -1.17B | -12.51%-3.8B | -26.38%-3.38B | -25.73%-2.67B | -25.67%-2.13B | -1.69B |
Gross profit | -47.11%239.93M | -50.87%637.72M | 453.65M | 6.17%1.3B | 20.88%1.22B | 43.32%1.01B | 133.77%705.67M | 301.86M |
Selling expenses | 69.11%-67.71M | 43.29%-304.67M | ---219.23M | 1.40%-537.22M | -20.70%-544.84M | -24.70%-451.41M | -6.47%-361.99M | ---340.01M |
Administrative expenses | 34.53%-94.13M | -89.20%-288.58M | ---143.77M | -4.46%-152.53M | -112.02%-146.01M | -64.02%-68.87M | -59.62%-41.99M | ---26.3M |
Research and development expenses | 43.62%-65.46M | 14.66%-200.84M | ---116.11M | -13.22%-235.33M | -33.03%-207.85M | -18.32%-156.24M | -63.91%-132.05M | ---80.56M |
Impairment and provision | ---- | -86,199.11%-681.76M | ---681.76M | ---790K | ---- | ---1.87B | ---- | ---- |
-Goodwill impairment | ---- | -86,199.11%-681.76M | ---681.76M | ---790K | ---- | ---1.87B | ---- | ---- |
Special items of operating profit | -32.17%20.22M | -37.34%48.91M | --29.81M | 13.37%78.06M | 11.58%68.85M | 80.81%61.71M | 185.24%34.13M | --11.97M |
Operating profit | 104.85%32.85M | -275.30%-789.22M | -677.42M | 14.63%450.2M | 126.61%392.73M | -824.36%-1.48B | 253.15%203.76M | -133.05M |
Financing cost | 55.20%-478K | 27.70%-1.67M | ---1.07M | -375.83%-2.3M | 37.63%-484K | -24.36%-776K | ---624K | ---- |
Special items of earning before tax | ---- | ---- | ---- | ---154.9M | ---- | ---- | ---- | ---- |
Earning before tax | 104.77%32.37M | -369.92%-790.88M | -678.48M | -25.30%293M | 126.56%392.25M | -826.96%-1.48B | 252.68%203.14M | -133.05M |
Tax | 120.90%2.13M | 89.83%-6.23M | ---10.19M | 8.88%-61.26M | -40.30%-67.23M | -304.64%-47.92M | 78.08%-11.84M | ---54.02M |
After-tax profit from continuing operations | 105.01%34.5M | -443.96%-797.11M | -688.67M | -28.70%231.75M | 121.32%325.02M | -897.01%-1.52B | 202.26%191.3M | -187.07M |
Earning after tax | 105.01%34.5M | -443.96%-797.11M | -688.67M | -28.70%231.75M | 121.32%325.02M | -897.01%-1.52B | 202.26%191.3M | -187.07M |
Minority profit | 170.59%12K | -468.29%-233K | ---17K | ---41K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 105.01%34.49M | -443.80%-796.88M | -688.66M | -28.69%231.79M | 121.32%325.02M | -897.01%-1.52B | 202.26%191.3M | -187.07M |
Basic earnings per share | 104.35%0.03 | -433.33%-0.8 | -0.69 | -29.41%0.24 | 0.34 | |||
Diluted earnings per share | 104.35%0.03 | -433.33%-0.8 | -0.69 | -29.41%0.24 | 0.34 | |||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | KPMG | KPMG | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data